Micromonospora chalcea (Foulerton) Orskov (ATCC® 12452)

Strain Designations: 1464-217L  /  Type Strain: yes  /  Biosafety Level: 1

Permits and Restrictions

View Permits

Strain Designations 1464-217L
Application
Produces restriction endonuclease MchI
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Comments
Oxidative conversion of 3-keto-nuclear-saturated steroids to corresponding delta 1,4-steroids compounds
Colonial development
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Chas. Pfizer & Co., Inc.
References

Shull GM. Preparation of 3-keto-delta1,4-steroids from 3-keto-delta4-steroids with Micromonospora. US Patent 2,809,919 dated Oct 15 1957

Shull GM. Preparation of delta1,4 steroid compounds by Micromonospora. US Patent 2,890,153 dated Jun 9 1959

Luedemann GM. Designation of neotype strains for Micromonospora coerulea Jensen 1932 and Micromonospora chalcea (Foulerton 1905) Orskov 1923. Int. J. Syst. Bacteriol. 21: 248-253, 1971.

Suarez JE, Hardisson C. Morphological characteristics of colony development in Micromonospora chalcea. J. Bacteriol. 162: 1342-1344, 1985. PubMed: 3997781

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

type strain

type strain

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation